Williams v. Legacy Health

District Court, W.D. Washington·Decided August 29, 2024·No. 3:22-cv-06004·Unknown

Opinion

1 2 3

4 5 UNITED STATES DISTRICT COURT AT TACOMA 7 WILLIAMS et al, Case No. 3:22-cv-06004-TMC 8 Plaintiffs, ORDER GRANTING DEFENDANTS’ 9 MOTIONS FOR SUMMARY JUDGMENT v. 10 LEGACY HEALTH et al, 11 Defendants. 12 13

15 Plaintiffs Harold C. Williams, Jr., Toby Higa, Daniela Marianu, Angela Loghry, Ivan 16 Atanassov, Risa Brody, Aimee Sweet, Damaris Brici, and Brianna Hall are current or former 17 employees or contractors of Defendants Legacy Health and Northwest Acute Care Specialists. 18 During the COVID-19 pandemic, all of the plaintiffs worked in roles that required them to either 19 perform patient care or interact with patients and other healthcare workers on a daily basis. They 20 claim that Defendants failed to accommodate their religious beliefs when they did not approve 21 their applications for religious exemption from Defendants’ mandatory COVID-19 vaccination 22 policies. See Dkt. 1, 40. Plaintiffs assert that Defendants violated Title VII and the Washington 23 Law Against Discrimination (WLAD) when they failed to accommodate their bona fide religious 24 beliefs that led Plaintiffs to refuse vaccination. Id. Before the Court are Defendants’ motions for 1 summary judgment. Dkt. 35, 43. 2 In August 2021, as the Delta variant of COVID-19 spread rapidly around the world, the 3 Legacy health system began requiring all staff to be vaccinated against the disease. That same

4 month, Washington also instituted a requirement that all healthcare providers be vaccinated. 5 Both vaccination requirements allowed for consideration and accommodation of sincerely held 6 religious beliefs. Defendants have shown through undisputed evidence, however, that the nature 7 of Plaintiffs’ positions and work responsibilities in the Legacy health system—requiring close, 8 consistent, and frequent in-person contact with patients and staff—could not be accommodated 9 by a vaccine exemption. Even viewing the facts in the light most favorable to Plaintiffs, such an 10 accommodation would have imposed an undue hardship on Defendants by creating substantial 11 costs in terms of outsize risks to the health of their patients and staff, jeopardizing Defendants’ 12 ability to provide healthcare while safeguarding the health of patients and employees.

13 Because Legacy demonstrates that allowing Plaintiffs to work while unvaccinated posed 14 an undue hardship—and because Plaintiffs fail to provide contradictory evidence—the Court 15 GRANTS summary judgment in favor of Defendants. The following recitation of the facts is based on evidence in the summary judgment 17 record that is either undisputed or, where material factual disputes exist, taken in the light most 18 favorable to Plaintiffs. 19 20 A. The Legacy healthcare system and the beginning of the COVID-19 pandemic. Legacy is a regional non-profit healthcare system operating eight hospitals and over 21 seventy clinics in Oregon and Washington. See Dkt. 12; Dkt. 38 ¶ 4. Legacy has approximately 22 14,000 employees and 3,000 allied healthcare providers. Id. Among these employees were the 23 Plaintiffs, who worked in Legacy facilities in freight and mail distribution (Dkt. 39 at 2–3), as a 24 1 physician assistant (Dkt. 36 at 12), as respiratory therapists (see, e.g., id. at 162), and as 2 registered nurses in (among other departments) neonatal intensive care and surgery (see, e.g., id. 3 at 164, 167, 174). From the onset of the COVID-19 pandemic in early 2020, Legacy had to adapt

4 its facilities and policies, such as suspending elective or nonemergency surgeries, to protect 5 vulnerable patients and staff while treating an influx of COVID-19 patients. See Dkt. 38 ¶¶ 4–8. 6 COVID-19 is an easily transmitted disease, spread primarily through person-to-person 7 contact when an infected individual breathes out respiratory aerosols containing viral particles. 8 Dkt. 36 at 121. The disease is particularly dangerous to elderly and hospitalized individuals with 9 preexisting comorbidities. See id. at 120–21. 10 B. COVID-19 safety protocols and limitations 11 During the pandemic, Legacy implemented health safety protocols including, among 12 other things, the required use of personal protective equipment (PPE), COVID-19 testing,

13 temperature checks, social distancing, environmental disinfection, and room air changes. Id. ¶ 8. 14 Additionally, employees and contractors held daily meetings to discuss health safety and current 15 issues. Id. ¶ 9. Legacy also maintained hand hygiene, required self-reporting of illness and 16 symptoms, and sent frequent written updates regarding its workforce and changes in pandemic 17 conditions—including weekly and bi-monthly newsletters sent to staff and leadership, and a 18 weekly update focused specifically on COVID-19 issues. Id. 19 Legacy’s non-vaccine protocols had limits. For example, testing could fail to detect 20 COVID-19 until someone had been infected for several days, possibly infecting others in the 21 interim. Dkt. 36 at 128. And PPE could not be worn indefinitely, without interruption, and could 22 be worn improperly. Id. And by December 1, 2020, COVID-19-related hospitalizations and

23 deaths had continued to grow to the point where Legacy deployed refrigerated semi-truck trailers 24 as temporary morgues for deceased patients. See Dkt. 38 at 27–28. 1 C. COVID-19 Vaccines 2 On December 11, 2020, the United States Food and Drug Administration issued an 3 Emergency Use Authorization for the Pfizer BioNTech COVID-19 vaccine, followed by

4 authorizations for the Moderna vaccine on December 18, and the Johnson & Johnson vaccine in 5 February 2021. See Dkt. 36 at 122. The vaccines had been shown in clinical testing, leading up 6 to the emergency authorizations, to be safe and effective in preventing COVID-19 infections and 7 reducing the incidence of severe illness and death from the disease. Id. at 122–23. The Pfizer and 8 Moderna vaccines prevented COVID-19 cases in clinical testing participants between 94 and 95 9 percent of the time. Id. Although the vaccines’ efficacy at preventing infection waned over time, 10 particularly as the virus continued to mutate, their ability to prevent severe infection, 11 hospitalization, and death remained substantial. Id. The vaccines boosted antibody levels, 12 without the need for infection, which in turn reduced the likelihood of transmissibility and

13 symptoms. Id. Legacy received its first shipment of the Pfizer vaccines in mid-December 2020. 14 See Dkt. 38 ¶¶ 13–14, at 29. 15 D. Legacy’s implementation of its COVID-19 vaccination policy and exemptions Legacy distributed information on the COVID-19 vaccines promptly after they became 16 available, including via “town halls” and establishing a hotline for vaccine questions. See Dkt. 38 17 ¶¶ 11–12. Legacy administered most of its first shipment of vaccines within a week. Id. ¶¶ 13– 18 14. Legacy initially prioritized vaccinating employees who worked in units with high-COVID-19 19 exposure such as the emergency department and intensive care. Id. By March 4, 2021, most of 20 Legacy’s more than 17,000 employees, and older patients, were vaccinated. Id. ¶ 16. On July 1, 21 2021, however, approximately 2,240 employees remained unvaccinated. Id. ¶ 19. 22 Between June and September 2021, the spread of the more transmissible and severe Delta 23 variant of COVID-19 led to a 600% increase in hospital admissions and a peak daily death toll of 24 1 1,500 Americans. Dkt. 36 at 122–23. By late July, Legacy’s own projections modeled an 2 unprecedented increase in COVID-19 cases across its system. See Dkt. 38 ¶¶ 16–17, at 43–46. 3 Legacy’s leadership team determined that its non-vaccine-based protocols would be insufficient

4 to safeguard staff and patients, many of whom were especially at-risk of illness and death from 5 COVID-19 due to age or existing conditions. Id. ¶ 24, 28.

Free access — add to your briefcase to read the full text and ask questions with AI

Williams v. Legacy Health, (W.D. Wash. 2024).

Williams v. Legacy Health (Williams v. Legacy Health) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.

Related

Anderson v. Liberty Lobby, Inc.
477 U.S. 242 (Supreme Court, 1986)
Lujan v. National Wildlife Federation
497 U.S. 871 (Supreme Court, 1990)
Tolan v. Cotton
134 S. Ct. 1861 (Supreme Court, 2014)
Kumar v. Gate Gourmet, Inc.
325 P.3d 193 (Washington Supreme Court, 2014)
Keenan v. Allan
91 F.3d 1275 (Ninth Circuit, 1996)
Balint v. Carson City
180 F.3d 1047 (Ninth Circuit, 1999)